Seeing Is Believing

Currently out of the existing stock ratings of Reni Benjamin, 255 are a BUY (87.03%), 38 are a HOLD (12.97%).
Analyst Reni Benjamin, currently employed at JMP, carries an average stock price target met ratio of 47.12% that have a potential upside of 50.48% achieved within 288 days. Previously, Reni Benjamin worked at RAYMOND JAMES, HC WAINWRIGHT.
Reni Benjamin’s has documented 530 price targets and ratings displayed on 45 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on CMPX, Compass Therapeutics at 23-Sep-2026.
Analyst best performing recommendations are on IOVA (IOVANCE BIOTHERAPEUTICS).
The best stock recommendation documented was for IOVA (IOVANCE BIOTHERAPEUTICS) at 3/3/2026. The price target of $5 was fulfilled within 3 days with a profit of $1.25 (33.33%) receiving and performance score of 111.11.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 02-Mar-2022
$14
$10.62 (314.20%)
$15
2 months 3 days ago
(30-Jul-2026)
0/24 (0%)
$9.99 (249.13%)
Hold Since 15-Feb-2022
$12
$7.9 (192.68%)
5 months 25 days ago
(08-Apr-2026)
0/8 (0%)
$7.02 (140.96%)
Buy Since 12-Jun-2020
$36
$32.62 (965.09%)
$36
6 months ago
(03-Apr-2026)
3/11 (27.27%)
$30.95 (612.87%)
192
Hold Since 18-Mar-2026
$7
$2.9 (70.73%)
6 months 15 days ago
(18-Mar-2026)
0/3 (0%)
$2.3 (48.94%)
Hold Since 24-Nov-2025
$10
$5.9 (143.90%)
$25
10 months 9 days ago
(24-Nov-2025)
0/5 (0%)
$3.26 (48.37%)
Which stock is Reni Benjamin most bullish on?
Which stock is Reni Benjamin most reserved on?
What Year was the first public recommendation made by Reni Benjamin?